182 related articles for article (PubMed ID: 21317706)
1. S100P expression in ductal type of carcinoma ex pleomorphic adenoma.
Hashimoto K; Yamamoto H; Shiratsuchi H; Nakashima T; Tamiya S; Higaki Y; Komune S; Tsuneyoshi M; Oda Y
Am J Surg Pathol; 2011 Mar; 35(3):346-55. PubMed ID: 21317706
[TBL] [Abstract][Full Text] [Related]
2. HER-2/neu gene amplification in carcinoma ex pleomorphic adenoma in relation to progression and prognosis: a chromogenic in-situ hybridization study.
Hashimoto K; Yamamoto H; Shiratsuchi H; Nakashima T; Tamiya S; Nishiyama K; Higaki Y; Komune S; Tsuneyoshi M; Oda Y
Histopathology; 2012 May; 60(6B):E131-42. PubMed ID: 22486195
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical study of XIAP expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Hoch BL; Wu M; Lewis M; Gan L; Burstein DE
J Oral Pathol Med; 2008 Nov; 37(10):634-8. PubMed ID: 18673415
[TBL] [Abstract][Full Text] [Related]
4. Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression.
Altemani A; Martins MT; Freitas L; Soares F; Araújo NS; Araújo VC
Histopathology; 2005 Jun; 46(6):635-41. PubMed ID: 15910594
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Ki-67, cyclin E, and p63 in benign and malignant human pleomorphic adenoma.
Zhu X; Zhang J; Chen X; Feng X
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 May; 113(5):667-72. PubMed ID: 22668626
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 and p16 expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma of the parotid gland.
Patel RS; Rose B; Bawdon H; Hong A; Lee CS; Fredericks S; Gao K; O'Brien CJ
Histopathology; 2007 Nov; 51(5):691-6. PubMed ID: 17927591
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical evaluation of androgen receptor, HER-2/neu, and p53 in benign pleomorphic adenomas.
DeRoche TC; Hoschar AP; Hunt JL
Arch Pathol Lab Med; 2008 Dec; 132(12):1907-11. PubMed ID: 19061288
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of cyclooxygenase-2 and Ki-67 are associated with malignant transformation of pleomorphic adenoma.
Katori H; Nozawa A; Tsukuda M
Auris Nasus Larynx; 2007 Mar; 34(1):79-84. PubMed ID: 17049779
[TBL] [Abstract][Full Text] [Related]
9. Intraductal carcinoma is the precursor of carcinoma ex pleomorphic adenoma and is often associated with dysfunctional p53.
Ihrler S; Weiler C; Hirschmann A; Sendelhofert A; Lang S; Guntinas-Lichius O; Arnold G; Zietz C; Harrison JD
Histopathology; 2007 Sep; 51(3):362-71. PubMed ID: 17593217
[TBL] [Abstract][Full Text] [Related]
10. Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma.
de Brito BS; Giovanelli N; Egal ES; Sánchez-Romero C; Nascimento JS; Martins AS; Tincani ÁJ; Del Negro A; Gondak RO; Almeida OP; Kowalski LP; Altemani A; Mariano FV
Hum Pathol; 2016 Nov; 57():152-159. PubMed ID: 27473265
[TBL] [Abstract][Full Text] [Related]
11. Cyclin A expression and its diagnostic value in pleomorphic adenoma and carcinoma expleomorphic adenoma of the parotid gland.
Patel RS; Hughes CW; Fredericks S; Lee CS; Rose B; Gao K; Smith G; Hong A; O'Brien CJ
Histopathology; 2007 Jul; 51(1):21-5. PubMed ID: 17593077
[TBL] [Abstract][Full Text] [Related]
12. Carcinoma ex pleomorphic adenoma: diagnostic difficulty and outcome.
Zbären P; Zbären S; Caversaccio MD; Stauffer E
Otolaryngol Head Neck Surg; 2008 May; 138(5):601-5. PubMed ID: 18439465
[TBL] [Abstract][Full Text] [Related]
13. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B
Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090
[TBL] [Abstract][Full Text] [Related]
14. Dual gain of HER2 and EGFR gene copy numbers impacts the prognosis of carcinoma ex pleomorphic adenoma.
Nishijima T; Yamamoto H; Nakano T; Nakashima T; Taguchi K; Masuda M; Motoshita J; Komune S; Oda Y
Hum Pathol; 2015 Nov; 46(11):1730-43. PubMed ID: 26345124
[TBL] [Abstract][Full Text] [Related]
15. Study of histopathological, morphological and immunohistochemical features of recurrent pleomorphic adenoma: an attempt to predict recurrence of pleomorphic adenoma.
Soares AB; Altemani A; de Araújo VC
J Oral Pathol Med; 2011 Apr; 40(4):352-8. PubMed ID: 20969626
[TBL] [Abstract][Full Text] [Related]
16. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
17. Expression of epidermal growth factor receptor, transforming growth factor-alpha and Ki-67 in relationship to malignant transformation of pleomorphic adenoma.
Katori H; Nozawa A; Tsukuda M
Acta Otolaryngol; 2007 Nov; 127(11):1207-13. PubMed ID: 17851915
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma ex pleomorphic adenoma of the salivary gland: an immunohistochemical study.
Matsubayashi S; Yoshihara T
Eur Arch Otorhinolaryngol; 2007 Jul; 264(7):789-95. PubMed ID: 17310348
[TBL] [Abstract][Full Text] [Related]
19. Biomarker analysis in carcinoma ex pleomorphic adenoma at an early phase of carcinomatous transformation.
Freitas LL; Araújo VC; Martins MT; Chone C; Crespo A; Altemani A
Int J Surg Pathol; 2005 Oct; 13(4):337-42. PubMed ID: 16273189
[TBL] [Abstract][Full Text] [Related]
20. Study of growth factors and receptors in carcinoma ex pleomorphic adenoma.
Furuse C; Miguita L; Rosa AC; Soares AB; Martinez EF; Altemani A; de Araújo VC
J Oral Pathol Med; 2010 Aug; 39(7):540-7. PubMed ID: 20149060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
